Metabolomics for Prediction of Relapse in Graves' Disease: Observational Pilot Study

Background: There is a lack of biochemical markers for early prediction of relapse in patients with Graves' disease [GD], which may help to direct treatment decisions. We assessed the prognostic ability of a high-throughput proton NMR metabolomic profile to predict relapse in a well characteriz...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Front Endocrinol (Lausanne)
Egile Nagusiak: Struja, Tristan, Eckart, Andreas, Kutz, Alexander, Huber, Andreas, Neyer, Peter, Kraenzlin, Marius, Mueller, Beat, Meier, Christian, Bernasconi, Luca, Schuetz, Philipp
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2018
Gaiak:
Endocrinology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6199355/
https://ncbi.nlm.nih.gov/pubmed/30386302
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2018.00623
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak